Biotechnology

NRx is a clinical-stage pharmaceutical company that is developing ZYESAMI (aviptadil acetate) for COVID-19 and NRX-101, the first oral therapeutic for the treatment of Acute Suicidal Behavior/Ideation (ASIB) in Bipolar Disorder.

Azafaros is developing new treatment options to help patients with rare metabolic disorders. Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with disease-modify

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.

CANCER FUND is a community of individuals investing together to support the development and commercialization of promising cancer innovations with the potential to help patients, survivors, previvors, and the people that care for them. Learn more or join us at www.cancerfund.com.

Innophore specializes in enzyme discovery, drug discovery, molecular dynamics simulations and biopharmaceutical services.

The Catalytic Platform integrates and scales the scientific workflows required to create new insights and achieve R&D milestones faster.

CARsgen is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.

Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases.

AnaSpec, a subsidiary of Kaneka Eurogentec, is a globally recognized biotechnology company that manufactures and sells custom and catalog Peptides, Fluorogenic and FRET Assay Kits, Fluorescent Dyes, Amino Acids and more, for research use, drug discovery and diagnostic use. We also manufacture cust

Sable Systems International is a biotechnology company for precision metabolic measurement.

Complement Therapeutics operates as a preclinical stage company.

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

WhiteLab Genomics develops a proprietary platform that leverages graph knowledge technology and machine learning to help companies discover and design new genomic therapies. WhiteLab Genomics enables genomic medicine scientists to obtain precise and comprehensive answers to key scientific and techno

1nHealth is a digital technology company utilizing big data analysis to tap qualified and engaged subjects that others ignore. By analyzing consumer behaviors, instead of channel targeting, they bring subjects who match the inclusion criteria for the clinical study.

Medical technology now allows for cancer to be detected in a patient’s blood through cell-free DNA (cfDNA). Quantgene has developed a method for Deep Human Genome sequencing which allows us to see mutational patterns of disease down to a single molecule. This means diseases like cancer can be detect

Neomorph is a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets’.

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies.

Pulse Biosciences is a novel medical therapy company bringing to market its proprietary Nano-Pulse Stimulation™ (NPS™) platform.

Mestastop Solutions aims to make a difference by understanding metastasis biology and addressing it, for both diagnostics and discovery.

Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.

Three established Finnish life science & diagnostics pioneers Abacus Diagnostica, Labrox and Kaivogen have merged into Uniogen. Uniogen is specialized in molecular and immunoassay diagnostics of infectious diseases, cancer diagnostics, and laboratory instrumentation. We are targeting the global mark

At Tema we build innovative portfolio building blocks in life sciences, strategic equity and alternatives. These ETF solutions strengthen existing core holdings and help investors achieve better outcomes through bottom-up active investing. Tema is backed by Index Ventures and Accel Ventures and seve

ExpreS2ion Biotechnologies is a biotech company within protein production in Drosophila Schneider-2 (S2) cells.

Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Its mission is to development a new drug to treat Glioblastoma Multiforme.

For over 70 years, BioZyme has pioneered innovative solutions in animal well-being and nutrition through supplements, health products, and feed additives. As an industry leader in fermentation, BioZyme has made it our mission to improve the quality of your animals’ lives. How? By offering innovative

Amelia leverages the human genome in order to find solutions to aging related disorders

Torus Biosystems is developing the next generation of POC molecular diagnostics for syndromic infectious diseases based on the novel integration of qPCR and microarray technologies that enable detection and quantification of DNA in under 30 minutes.

Oncorus is a pre-clinical stage biotechnology company developing innovative and impactful, next-generation oncolytic HSV products with unprecedented potential to recruit all arms of the immune system to treat solid tumors.

Fulcrum Genomics is a bioinformatics consulting company.

Clean TeQ was founded in 1990, to provide air pollution control solutions, primarily using biotechnology-based processe

Camallergy develops and provides new treatments for common food allergies.

Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer.

At Aerbio, we’re powering the future of fermentation technology. We utilise hydrogen and carbon dioxide, instead of sugar, to fuel the creation of a range of products. Leading the charge with our groundbreaking single cell protein, Proton™, we are boldly redefining sustainability and innovation in

Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic designed to be a superior and safer Vitamin K antagonist (VKA) anticoagulant for patients with implanted cardiac devices or rare cardiovascular (CV) conditions. Cadrenal strives to improve outc

AOA Dx Inc is a biotech company focused on early-stage cancer detection.

BioDuro is a global provider of contract research, development and manufacturing outsourcing solutions. Pharmaceutical, biotechnology and virtual companies are offered a comprehensive array of scientific services spanning the drug discovery and development continuum.

Shuttle Pharmaceuticals is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies.

B-TEMIA develops, manufactures and commercializes cutting-edge products in the growing market of human augmentation systems.

PROMETRIKA is a global full-service clinical research organization (CRO) with extensive experience in clinical operations, data management, biostatistics, medical writing, and pharmacovigilance.

Gemelli Biotech is a specialty biotechnology company that strives to achieve a thriving global family of healthy individuals by unlocking the potential of the microbiome. Gemelli’s mission is to support the discovery of novel diagnostics and therapeutics for the human microbiome by bringing biotechn

Saphetor is a personalised medicine company.

Cellares is revolutionizing cell therapy manufacturing. Cellares is developing a one-of-a-kind solution, The Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patients who can benefit.

Venebio solves complex life sciences problems for a range of organizations including pharmaceutical companies, biotechnology.

Salarius Pharmaceuticals is an oncology based biotechnology company.

Boyd Technologies is an advanced materials and technology company operating in the medical device and life sciences market.

2cureX operates as a medtech company in Denmark.

CTx is preclinical biotech developing the second generation of therapeutic & intelligent mRNA.

Samumed is a leader in medical research and development for tissue-level regeneration. With their platform's origins in small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.